The CDC already recommends the RSV shot for all adults 75 and older and for people 60 and older who have health conditions that increase their risk of severe RSV.

The vaccines are intended to be developed for use against Marburg virus and Sudan ebolavirus, two hemorrhagic fevers in the same family as the Ebola virus ...

The CDC director typically signs off on the panel's recommendations before they are implemented, but the agency does not currently have one. President Donald Trump 's nominee for the post, Susan ...

RSV vaccine access expanded to some people in their 50s, according to CDC website The Trump administration appears to be expanding RSV vaccinations to some adults starting at age 50 instead of 60 ...

Meissner also expressed how thoroughly the CDC panel’s work group on RSV examined the data. “We went through the details very, very carefully, and I appreciate Dr. [Levi’s] careful review of ...

The U.S. CDC recommends RSV vaccines for high-risk adults aged 50-59, endorsing the views of the former vaccine advisory panel. Read more here.

RSV vaccine access expanded to some people in their 50s, according to CDC website The decision appears on a CDC webpage but wasn’t on the agency’s official adult immunization schedule.

CDC panel recommends RSV shot for babies By Mary Kekatos, ABCNews Thursday, June 26, 2025 Stream New York's #1 news - Accuweather - original content 24/7 ...

The CDC noted that, at this time, RSV vaccination is recommended as a single dose only. People who have already received an RSV vaccination are not recommended to receive another dose.

The new drug was approved this month by the FDA, and the CDC committee’s recommendation was the next step in making it widely available for the coming RSV season, which typically begins in the fall.

US CDC Accepts Ousted Vaccine Panel's Recommendations for RSV, Meningococcal Shots (Reuters) -The U.S. Centers for Disease Control and Prevention has accepted recommendations made by a panel of ...

The CDC currently recommends RSV vaccines for adults 75 and older, plus those 60-74 at increased risk. The final CDC recommendation remains pending for the expanded age group before availability.